Browse Category

Health News News: 12 August 2025 - 16 September 2025

Possible Life on Mars, ‘Black Hole Stars’ and a Global Diabetes Bombshell – Science News Roundup (Sept 15–16, 2025)

NASA Rover Finds Possible Biosignature – Closest Hint Yet of Life on Mars In a sensational development for astrobiology, NASA announced that Perseverance has collected a Mars rock sample that “could preserve

16 September 2025

COVID Booster Shocker, Pharma Mega-Deals & Alzheimer’s Breakthroughs – Global Health Roundup (Aug 28–29, 2025)

Drug Approvals & Clinical Trial Results Updated COVID Boosters Get Narrow Nod: The U.S. FDA approved new fall COVID-19 booster shots from Pfizer/BioNTech and Moderna on August 27 – but with strict

29 August 2025

COVID-19 · Global Health · Health News · Medical Breakthroughs · Pharmaceuticals

Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights Medical Research & Innovation Public Health & Policy Developments Sources: Ionis HAE drug approval pharmexec.com biopharmadive.com; BioPharmaDive on

23 August 2025

Biotech · Health News · Medical Research · Pharmaceuticals · Public Health

Biotech Breakthroughs, Pharma Shakeups & Health Alerts – Global News Roundup (Aug 19–20, 2025)

Major Corporate & Industry Announcements Clinical Trials & Drug Regulatory Updates Scientific & Medical Research Breakthroughs (Note: The above research highlights were reported in peer-reviewed journals and scientific news outlets around this

20 August 2025

Biotechnology · Global News · Health News · Medical Research · Pharmaceuticals

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy (semaglutide) received FDA accelerated approval to treat metabolic dysfunction-associated steatohepatitis (MASH), becoming the first GLP-1 therapy cleared for MASH in a patient population estimated at about 5% of U.S. adults, based

16 August 2025

Biotechnology · Health News · Medical Innovations · Mergers & Acquisitions · Pharmaceuticals

Blockbuster Breakthroughs, Setbacks & Surges: Biotech and Health News Roundup (Aug 11–12, 2025)

IO Biotech’s Phase 3 melanoma vaccine Cylembia added to Merck’s Keytruda narrowly missed statistical significance, with median progression-free survival of 19.4 months versus 11 months for Keytruda alone. Fosun Pharma’s deal with

12 August 2025

Biotech · Health News · Health Technology · Medical Research · Scientific Breakthroughs

Go toTop